[1] 程光荣,郭丽萍.原发性肝癌患者接受肝动脉灌注化疗栓塞术后护理康复效果分析.实用肝脏病杂志,2016,19(6):700-703. [2] Lin Y,Feng J, Yang D,et al.Suppression of human hepatoma growth in vivo by a monoclonal antibody against a Mr 45,000 protein.Cancer Invest,2006,24(8):734-739. [3] Mokdad AA, Singal AG, Yopp AC.Treatment of liver cancer. JAMA,2016,315(1):100. [4] 张跃伟. 微创介入治疗原发性肝癌对机体免疫功能影响的研究现状与展望.实用肝脏病杂志,2014,11(3):231-233,234. [5] Xing M, Lahti S, Kokabi N, et al.90Y radioembolization lung shunt fraction in primary and metastatic liver cancer as a biomarker for survival. Clin Nucl Med,2016, 41(1):21-27. [6] Zhang N, Chen H,Liu AY, et al.Gold conjugate-based liposomes with hybrid cluster bomb structure for liver cancer therapy. Biomaterials, 2016,74:280-291. [7] Mokdad AA, Singal AG,Yopp AC.Liver cancer. JAMA,2015,314(24):2701. [8] 阳腾飞,黄仲奎,龙莉玲,等.采用扩散峰度成像评估PLC及其周围肝实质肿瘤浸润的价值.中华放射学杂志,2017,51(3):174-177. [9] Dransfield DT, Cohen EH, Chang Q,et al.A human monoclonal antibody against insulin-like growth factor-II blocks the growth of human hepatocellular carcinoma cell lines in vitro and in vivo.Mol Cancer Ther,2010,9(6):1809-1819. [10] Patman G.Liver cancer: A model of fibrolamellar carcinoma. Nature reviews. Gastroenterol Hepatol,2015,12(12):672. [11] Reul J.Treatment of lumbar disc herniations by interventional fluoroscopy-guided endoscopy. Interv Neuroradiol,2014,20(5):538-546. [12] Machado MC,Bellodi-Privato M, Kubrusly MS,et al.Valproic acid inhibits human hepatocellular cancer cells growth in vitro and in vivo.J Exp Ther Oncol,2011,9(2):85-92. [13] Yoshida M,Hori M, Yokoyama K,et al.Diffusional kurtosis imaging of normal-appearing white matter in multiple sclerosis: Preliminary clinical experience. Jpn J Radiol,2013, 31(1): 50-55. [14] Hou J, Wang D, Zhang R,et al.Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action.Clin Cancer Res,2008,14(17):5519-5530. [15] 闫坤,胡莎莎,杨品,等.磁共振扩散峰度成像在肿瘤中的研究进展.磁共振成像,2016,7(8):635-640. |